Riskpilot← Back to searchSign inGet full accessSantenPharma AB
ABIn liquidationOrg 5565408167Activities of advertising agencies · NACE 7311Est. 19970 employees
Revenue 2022
SEK 25,9M
-48% vs 2021
EBITDA margin
7.2%
-48% vs 2021
Equity ratio
63.0%
Financial strength
Net profit 2022
SEK 1,2M
-51% vs 2021
| Revenue | SEK 25,9M | -48% |
| EBITDA | SEK 1,9M | -48% |
| Net profit | SEK 1,2M | -51% |
| Total assets | SEK 5,6M | -79% |
| Equity | SEK 3,5M | -79% |
| Employees | 0 | — |
Legal name
SantenPharma AB
Org number
5565408167
Legal form
Aktiebolag
NACE code
7311 · Activities of advertising agencies
Founded
1 april 1997
Share capital
SEK 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-03-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall marknadsföra och främja avsättning av läkemedels- produkter i Norden samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 42 190 | 49 165 | 50 112 | 25 905 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 2 084 | 2 530 | 2 278 | 2 454 | 3 346 | 3 600 | 1 854 |
| Depreciation & amort. | −163 | −180 | −110 | −70 | −117 | −292 | −155 |
| EBIT | 1 921 | 2 350 | 2 168 | 2 384 | 3 229 | 3 308 | 1 699 |
| Net financials | −1 | — | — | −1 | −2 | 1 | −1 |
| Profit before tax | 1 920 | 2 351 | 2 168 | 2 383 | 3 227 | 3 309 | 1 698 |
| Tax | −681 | −853 | −970 | −945 | −1 185 | −855 | −487 |
| Net profit | 1 239 | 1 498 | 1 198 | 1 438 | 2 042 | 2 454 | 1 211 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Total assets | 13 548 | 14 489 | 16 529 | 19 393 | 23 096 | 26 717 | 5 632 |
| Equity | 8 205 | 9 702 | 10 901 | 12 338 | 14 381 | 16 835 | 3 546 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 343 | 4 787 | 5 628 | 7 054 | 8 715 | 9 883 | 2 085 |
| Total debt | 5 343 | 4 787 | 5 628 | 7 054 | 8 715 | 9 883 | 2 085 |
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
20162022
Equity ratio
63.0%
This company
38.2%
Market median
+65% vs market
20162022
Return on equity
34.2%
This company
18.4%
Market median
+86% vs market
20162022
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20162022
Asset turnover
4.60×
This company
1.12×
Market median
+311% vs market
20162022
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20162022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-04-01 – 2018-03-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-04-01 – 2017-03-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-04-01 – 2016-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EC Chief Auditor | Chief Auditor | 2022 | — | — |
LA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LR | Audit | 2020 | — | — |
JF Liquidator | Liquidator | 2022 | — | — |
AM Chief Auditor | Chief Auditor | 2020 | — | — |
PA Authorized Recipient of Service | Authorized Recipient of Service | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Servando Snabbavveckling AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Servando Bolag AB
SantenPharma AB Board members of SantenPharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elna Catrin Moberg | Chief Auditor | 0 companies |
| Lasse Antero Kovalainen | Chief Executive Officer | 0 companies |
| Lars Rickard Jäderström | Audit | 0 companies |
| Johan Fredrik Ståhl | Liquidator | 0 companies |
| Anette Margareta Envall Svahn | Chief Auditor | 0 companies |
| Per Anders Söderlind | Authorized Recipient of Service | 0 companies |
| Luis Miguel Iglesias Fernandez | Chairman | 0 companies |
| Annelie Elisabeth Thunström | Board of Directors | 0 companies |
| Christopher Paul Reindel | Board of Directors | 0 companies |
| Maria Elisabeth Edward | Deputy Board Member | 0 companies |